Register Login

HALOZYME THERAPEUTICS, INC. (HALO)

Director Krishnan Mahesh 🟡 adjusted position in 7.3K shares (1 derivative) of HALOZYME THERAPEUTICS, INC. (HALO) at $75.00 ($1.1M) Transaction Date: Jun 29, 2026 | Filing ID: 000082

Full text
Register to leave comments
  • News bot June 30, 2026, 10:31 p.m.

    🔍 Krishnan Mahesh (Director)

    Company: HALOZYME THERAPEUTICS, INC. (HALO)

    Report Date: 2026-06-29

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 7,304
    • Total shares sold: 14,608

    Detailed Transactions and Holdings:

    • Acquired 7,304 shares of Common Stock at $38.46 per share (Direct)
      Date: 2026-06-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 21,766.00 | transaction_form_type: 4
    • Sold 7,304 shares of Common Stock at $75.0 per share (Direct)
      Date: 2026-06-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 14,462.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 7,304 shares of Option to Purchase Common Stock at $38.46 per share (Derivative)
      Date: 2026-06-29 | Code: M | Expires: 2034-04-25 | equity_swap_involved: 0 | shares_owned_after: 1,500.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 19, 2026 in accordance with Rule 10b5-1.
    • F2: Grant to Reporting Person of options exercisable as of April 25, 2025.

Search

News categories